Global and China Dermatology Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

    This report elaborates on the current development of the Dermatology Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Galderma

    • Johnson & Johnson

    • Merz Pharma

    • Bristol-Myers Squibb

    • GlaxoSmithKline

    • Bayer

    • Pfizer

    • LEO Pharma

    • Valeant

    • AbbVie

    • Novartis

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • External Use

    • Oral

    • Injection

    Application:

    • Psoriasis

    • Skin Infections

    • Acne

    • Dermatitis

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Dermatology Drugs Industry Overview

      • 1.1.1 Dermatology Drugs Market Scope and Market Segments

      • 1.1.2 Dermatology Drugs Industry Characteristics

      • 1.1.3 Global and China Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Dermatology Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Dermatology Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 External Use

      • 1.2.2 Oral

      • 1.2.3 Injection

    • 1.3 Global Dermatology Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Psoriasis

      • 1.3.2 Skin Infections

      • 1.3.3 Acne

      • 1.3.4 Dermatitis

      • 1.3.5 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Dermatology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Dermatology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Dermatology Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Dermatology Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Dermatology Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Dermatology Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Dermatology Drugs Industry PEST Analysis

    • 2.3 Dermatology Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Dermatology Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Dermatology Drugs Industry

    Chapter 3 Global and China Dermatology Drugs Market, by Manufacturer

    • 3.1 Global and China Dermatology Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Dermatology Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Dermatology Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Dermatology Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Dermatology Drugs Market Top 3 Players

    Chapter 4 Global and China Dermatology Drugs Market, by Type (2017-2028)

    • 4.1 Dermatology Drugs Market Trend, by Type

    • 4.2 Global Dermatology Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Dermatology Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Dermatology Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Dermatology Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Dermatology Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Dermatology Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Dermatology Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Dermatology Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Dermatology Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Dermatology Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Dermatology Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Dermatology Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Dermatology Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Dermatology Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Dermatology Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Dermatology Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Dermatology Drugs Market Analysis

    • 7.1 North America Dermatology Drugs Market, by Type

    • 7.2 North America Dermatology Drugs Market, by Application

    • 7.3 North America Dermatology Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Dermatology Drugs Market Analysis

    • 8.1 Europe Dermatology Drugs Market, by Type

    • 8.2 Europe Dermatology Drugs Market, by Application

    • 8.3 Europe Dermatology Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Dermatology Drugs Market Analysis

    • 9.1 APAC Dermatology Drugs Market, by Type

    • 9.2 APAC Dermatology Drugs Market, by Application

    • 9.3 APAC Dermatology Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Dermatology Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Dermatology Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Dermatology Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Dermatology Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Dermatology Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Dermatology Drugs Company Profiles

      • 11.1 Galderma

        • 11.1.1 Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Galderma Dermatology Drugs Product Profiles, Application and Specification

        • 11.1.3 Galderma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Johnson & Johnson

        • 11.2.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Johnson & Johnson Dermatology Drugs Product Profiles, Application and Specification

        • 11.2.3 Johnson & Johnson Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Merz Pharma

        • 11.3.1 Merz Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Merz Pharma Dermatology Drugs Product Profiles, Application and Specification

        • 11.3.3 Merz Pharma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bristol-Myers Squibb

        • 11.4.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bristol-Myers Squibb Dermatology Drugs Product Profiles, Application and Specification

        • 11.4.3 Bristol-Myers Squibb Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 GlaxoSmithKline

        • 11.5.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 GlaxoSmithKline Dermatology Drugs Product Profiles, Application and Specification

        • 11.5.3 GlaxoSmithKline Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Bayer

        • 11.6.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Bayer Dermatology Drugs Product Profiles, Application and Specification

        • 11.6.3 Bayer Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Dermatology Drugs Product Profiles, Application and Specification

        • 11.7.3 Pfizer Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 LEO Pharma

        • 11.8.1 LEO Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 LEO Pharma Dermatology Drugs Product Profiles, Application and Specification

        • 11.8.3 LEO Pharma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Valeant

        • 11.9.1 Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Valeant Dermatology Drugs Product Profiles, Application and Specification

        • 11.9.3 Valeant Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 AbbVie

        • 11.10.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 AbbVie Dermatology Drugs Product Profiles, Application and Specification

        • 11.10.3 AbbVie Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Novartis

        • 11.11.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Novartis Dermatology Drugs Product Profiles, Application and Specification

        • 11.11.3 Novartis Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Dermatology Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Dermatology Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Dermatology Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Dermatology Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Dermatology Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of External Use (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Psoriasis (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Skin Infections (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Acne (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Dermatitis (2017-2028)

    • Figure Global Dermatology Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Dermatology Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Dermatology Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Dermatology Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Dermatology Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Dermatology Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Dermatology Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Dermatology Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Dermatology Drugs Market Share, by Manufacturer in 2022

    • Table Global Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table Global Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Dermatology Drugs Sales Value, by Type (2017-2028)

    • Table Global Dermatology Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Dermatology Drugs Price Trend, by Type (2017-2028)

    • Table China Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table China Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Dermatology Drugs Sales Value, by Type (2017-2028)

    • Table China Dermatology Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Dermatology Drugs Price Trend, by Type (2017-2028)

    • Table Global Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table Global Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Dermatology Drugs Sales Value, by Application (2017-2028)

    • Table Global Dermatology Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Dermatology Drugs Sales Value Share, by Application (2017-2028)

    • Table China Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table China Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Dermatology Drugs Sales Value, by Application (2017-2028)

    • Table China Dermatology Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Dermatology Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Dermatology Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table North America Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table North America Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Dermatology Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Dermatology Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Dermatology Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Dermatology Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Dermatology Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Dermatology Drugs Sales Value and Growth Rate (2017-2028)

    • Table Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galderma Product Profiles, Application and Specification

    • Table Galderma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merz Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merz Pharma Product Profiles, Application and Specification

    • Table Merz Pharma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LEO Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LEO Pharma Product Profiles, Application and Specification

    • Table LEO Pharma Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Product Profiles, Application and Specification

    • Table Valeant Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Dermatology Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.